Baran Yılmaz Yücel

Executive Summary

Following the recent follow-on public offering announcement by AEVEX Corp. (NYSE: AVEX), this report evaluates the operational impact of the capital raise, the resulting shareholder dilution, and outlines a strategic, rule-based execution plan based on market structure and price action.

Ticker / Exchange: NYSE: AVEX

Catalyst: Follow-On Public Offering (Secondary Share Sale)

Daily Performance Impact: -11.93%

Analyst: Baran Yılmaz Yücel (Econometrics Student & Independent Financial Analyst)

🔍 The Catalyst: Follow-On Offering & Dilution Mechanics

AEVEX Corp. announced a public offering of 8 million Class A shares. The structure of the sale is divided as follows:

1. Primary Issuance (~5.7 million shares): Issued directly by the company. While this dilutes existing shareholder equity and earnings per share (EPS), it provides fresh liquidity.

2. Secondary Offering (~2.3 million shares): Sold by existing pre-IPO investors and insiders (Insider Selling).

For a company trading at a premium valuation of 110x P/E, the combination of new share dilution and insider liquidations has triggered immediate supply pressure. This supply-side shock is the primary driver behind the sharp -11.93% daily correction.

📊 Section 1: Fundamental Outlook & Operational Base

Despite the short-term market friction, AEVEX Corp.'s operational core remains robust:

Contract Backlog: High-volume defense contracts with the US Air Force ensure steady revenue streams.

Core Markets: Strong positioning in unmanned aerial vehicles (UAVs) and autonomous aerospace technologies.

Liquidity Injection: The estimated net proceeds from the ~5.7 million primary shares will directly fund R&D and capital expenditure for upcoming defense contracts.

Verdict: The capital injection is fundamentally constructive for long-term expansion, but the stretched valuation multiples (110x P/E) made the stock highly sensitive to any supply expansion, resulting in the current valuation reset.

🧮 Capital & Valuation Calculations

To understand the exact scale of this follow-on offering, we calculate the estimated capital flows and valuation benchmarks based on the Fair Value Gap (FVG) boundary levels:

1. Pre-Drop Share Price Estimate

Before the daily -11.93% drop to the upper FVG range ($36.27), the stock price is estimated as:

Pre-Drop Price = $36.27 / (1 - 0.1193) ≈ $41.18

2. Primary Capital Injection (Company Treasury)

The gross cash entering the AEVEX balance sheet from the sale of ~5.7 million new shares:

At FVG Upper ($36.27): 5,700,000 shares × $36.27 ≈ $206.74 Million

At FVG Lower ($33.24): 5,700,000 shares × $33.24 ≈ $189.47 Million

3. Secondary Insider Liquidation Scale

The value of the ~2.3 million shares liquidated by pre-IPO investors and insiders:

At FVG Upper ($36.27): 2,300,000 shares × $36.27 ≈ $83.42 Million

At FVG Lower ($33.24): 2,300,000 shares × $33.24 ≈ $76.45 Million

4. Total Combined Offering Volume

The total financial scale of the 8.0 million Class A share offering:

Total Offering Value = 8,000,000 × $36.27 ≈ $290.16 Million (at FVG Upper)

Total Offering Value = 8,000,000 × $33.24 ≈ $265.92 Million (at FVG Lower)

📈 Section 2: Technical Analysis & Market Mechanics

The panic-induced selling has accelerated a healthy econometric correction, bringing the price down to key structural demand zones. On the 4-hour (4H) timeframe, the price action presents a clear setup for accumulation.

Algorithmic Liquidity Gaps (FVG) & Dynamic Support

The -11.93% selloff drove the price directly into a major Fair Value Gap (FVG) on the chart:

Optimal Fair Value Gap Zone: $33.24 — $36.27. This range represents the primary imbalance area where selling pressure is expected to dry up and buyers will step in.

Dynamic Support (SMA 50): The 50-period Simple Moving Average is currently flatting out at $29.20, serving as the ultimate trend safety net.

🛠️ Section 3: Strategic Trade Playbook

Based on the alignment of the FVG imbalance zone and the dilution-driven discount, we outline the following strategic trade plan:

🎯 Optimal Entry Phase

Price Range: $33.24 — $36.27

Rationale & Strategy: This Fair Value Gap zone, where selling pressure from the follow-on offering will fade, is the optimal accumulation area where the liquidity gap is filled and the premium P/E ratio cools down.

📈 Take Profit Target

Target Level: $45.00 and above

Rationale & Strategy: Once the proceeds from the offering enter the company's treasury and convert into new defense contracts, the market is projected to forget the dilution effect and focus on long-term momentum.

🛑 Stop Loss Limit

Critical Level: Below $29.20

Rationale & Strategy: In case the FVG zone is violated and the SMA 50 is broken, the pricing logic is invalidated. A drop below this level indicates a structural issue in the company's cash-generation cycle.

Disclaimer

*The investment information, comments, charts, and analyses presented in this report are for educational and academic modeling purposes only and do not constitute investment advisory services. The analysis is based on publicly available data, prepared from an academic econometrics standpoint. Baran Yılmaz Yücel does not hold any authorized investment advisory or brokerage licenses, and cannot be held liable for any financial decisions made based on this report.*

AVEX Corp. (NYSE: AVEX): Analyzing Dilution Impact and FVG Accumulation Levels After Follow-On Offering